Drew Sansone

Drew Sansone has extensive experience in regulatory affairs, currently serving as Senior Vice President of Regulatory Affairs at Alkermes. Previously, Drew held the position of Chief Regulatory Officer at Tango Therapeutics. Additional roles include Vice President and Head of Global Regulatory Affairs/Regulatory and Quality for North America at Ipsen Bioscience US, as well as Regulatory Affairs Therapeutic Leader for Global Regulatory Strategy at AbbVie. Drew's career also includes serving as Executive Director of Global Regulatory Affairs at Tengion, Inc.